Gilead Sciences, Inc. (GILD)
144.19
-0.95
(-0.65%)
USD |
NASDAQ |
Mar 06, 10:26
Gilead Sciences Free Cash Flow : 9.456B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Johnson & Johnson | 19.70B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Arcellx, Inc. | -212.58M |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.327B |
| Cash from Investing (Quarterly) | -1.835B |
| Cash from Financing (Quarterly) | -1.263B |
| Free Cash Flow Per Share (Quarterly) | 2.492 |
| Free Cash Flow to Equity (Quarterly) | 2.522B |
| Free Cash Flow to Firm (Quarterly) | 3.390B |
| Free Cash Flow Yield | 5.22% |